LiYing Cai, M.D.
- Assistant Clinical Professor, Division of Cardiology, Department of Medical Specialties
LiYing Cai, M.D.
Areas of Expertise
- Chemotherapy induced heart failure
- Cardiac imaging
Other Languages Spoken
This is one of the best cancer institutes in the country.”
LiYing Cai, M.D., is a cardiologist with expertise in the diagnosis and management of heart disease. Dr. Cai received her medical degree from Beijing Medical University and a Ph.D. from Indiana University School of Medicine. She completed her cardiology fellowship training at the University of Chicago and there began to see cardio-oncology patients. She chose City of Hope to further her interest in an emerging field: the effects of cancer treatment on heart function.
Because radiation and some chemotherapy drugs can damage the heart, cardio-oncology is becoming increasingly important. It's vital to use all available research tools to learn more about the heart-cancer connection. It's equally critical to carefully monitor cancer patients for heart complications – and treat them quickly. At City of Hope, Dr. Cai looks forward to doing both.
- 2018-present, Assistant Clinical Professor, Division of Cardiology, Department of Medical Specialties, City of Hope, Duarte, CA
- 2015-2017, General Cardiologist, Beverly Hospital, Los Angeles, CA
- 2008, Ph.D., Department of Cellular Physiology, Indiana University School of Medicine, Indianapolis, IN
- 2002, M.D., Beijing Medical University, Beijing, China
- 2015, Cardiology, University of Chicago School of Medicine, Chicago, IL
- 2011, Internal Medicine, University School of Medicine, Reno, NV
- L. Cai, B.H. Johnstone, T.G. Cook, J. Tan, P.S. Chen, K.L. March. Human Adipose Tissue-Derived Stem Cells Induce Angiogenesis and Nerve Sprouting Following Myocardial Infarction, in Conjunction with Potent Preservation Of Cardiac Function. Stem Cells.2009 Jan:27(1):230-237.
- L.N. Bell, L. Cai, B.H. Johnstone, K.L. March, R.V. Considine. A Central Role for Hepatocyte Growth Factor in Adipose Tissue Angiogenesis. American Journal of Physiology-Endocrinology and Metabolism 2008 Feb;294(2):E336-44.
- L. Cai, B.H. Johnstone, T.G. Cook, Z. Liang, D. Traktuev, K.G. Cornetta, D.A. Ingram, E.D. Rosen, K.L. March. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells 2007 Dec;25(12):3234-43.
- 2015-present, American Society of Echocardiography, Member
- 2015-present, Society for Cardiovascular Magnetic Resonance, Member
- 2008-present, American College of Physicians, Member
- 2007-present, American College of Cardiology, Member
- 2005-present, American Heart of Association, Member
- 2007, International Fat Applied Technology Society annual conference, Excellent Research Award, Finalist
- 2005, American Heart Association Research Fellowship Award